Suchergebnisse - "Callen, J P"

PubPharm (308)

1

Anti-C1q antibodies in systemic lupus erythematosus

enthalten in: Lupus | 2015

von Orbai, A. | Truedsson, L. | Sturfelt, G. | +50

2

Anti-C1q antibodies in systemic lupus erythematosus

enthalten in: Lupus | 2015

von Orbai, A. | Truedsson, L. | Sturfelt, G. | +50

3

Hypertrophic lupus erythematosus complicating long-standing systemic lupus erythematosus

enthalten in: Lupus | 2011

von Bernardi, M. | Bahrami, S. | Callen, J.

4

Drug-induced subacute cutaneous lupus erythematosus

enthalten in: Lupus | 2010

von Callen, J.

5

Tissue Eosinophilia as an Indicator of Drug-Induced Leukocytoclastic Vasculitis: A Clinicopathologic Investigation

in: Journal of cutaneous pathology | 2005

von Bahrami, S. | Malone, J. | Webb, K. | +1

6

Pyoderma gangrenosum Preceding the Diagnosis of Systemic Lupus erythematosus

enthalten in: Dermatology | 2005

von Waldman, M. | Callen, J.

7

Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis

enthalten in: Clinical and experimental dermatology | 2004

von Waldman, M. | Black, D. | Callen, J.

8

Update on the management of cutaneous lupus erythematosus

enthalten in: The British journal of dermatology | 2004

von Callen, J.

9

Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis

in: Clinical and experimental dermatology | 2004

von Waldman, M. | Black, D. | Callen, J.

10

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus

enthalten in: Lupus | 2004

von Albrecht, J. | Berlin, J. | Braverman, I. | +11

ErratumIn: Lupus. 2005;14(2):178 Connolly, MK [added]

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]